Published in Br Med J on July 20, 1974
Factors predisposing to the development of progressive massive fibrosis in coal miners. Br J Ind Med (1981) 1.40
Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis (1993) 1.30
Frequency of HLA antigen in asbestos workers with and without pulmonary fibrosis. Br Med J (1977) 1.21
Silicosis among grindstone cutters in the north of Nigeria. Thorax (1975) 1.12
Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol (2001) 0.95
The HL-A system in asbestos workers. Br Med J (1975) 0.93
Prevalence and pathogenesis of pneumoconiosis in coal workers. Environ Health Perspect (1988) 0.81
Immunomodulation in mineral dust-exposed lungs: stimulatory effect and interleukin-1 release by neutrophils from quartz-elicited alveolitis. Clin Exp Immunol (1990) 0.78
An epidemiological study of rheumatoid arthritis associated with characteristic chest x-ray appearances in coal-workers. Br Med J (1953) 10.93
Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies. Clin Allergy (1971) 2.71
Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J (1970) 2.67
A broader concept of Caplan's syndrome related to rheumatoid factors. Thorax (1962) 2.51
Nervous outflow from the cat's foot during noxious radiant heat stimulation. Brain Res (1974) 2.18
Circulating antinuclear and rheumatoid factors in coal miners. A prevalence study in Pennsylvania and West Virginia. Ann Intern Med (1973) 1.76
Rheumatoid factor in serum of individuals exposed to asbestos. Ann N Y Acad Sci (1965) 1.65
Rheumatoid pneumoconiosis. A clinical study. Am Rev Respir Dis (1968) 1.08
Immunological aspects of coal workers' pneumoconiosis. Ann N Y Acad Sci (1972) 0.93
Antinuclear factor in pneumoconioses. N Engl J Med (1973) 0.86
On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest (1977) 6.54
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax (1980) 3.70
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies. Clin Allergy (1971) 2.71
Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J (1970) 2.67
Nocturnal asthma: a study in general practice. J R Coll Gen Pract (1989) 2.55
Cryptogenic fibrosing alveolitis and lung cancer. Thorax (1980) 2.31
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax (1980) 2.28
Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion. Thorax (1975) 2.28
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax (1980) 2.27
Relation between dust exposure and lung function in miners and ex-miners. Br J Ind Med (1986) 2.04
An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Occup Environ Med (2001) 2.03
Fibrosing alveolitis and chronic liver disease. Q J Med (1968) 1.91
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax (1980) 1.82
Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax (1981) 1.80
Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis (1981) 1.76
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax (1989) 1.75
Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med (1990) 1.71
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Epidemiological study of respiratory disease in workers exposed to polyvinylchloride dust. Thorax (1980) 1.69
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Respiratory and allergic symptoms in wool textile workers. Br J Ind Med (1988) 1.67
Nocturnal asthma and urinary adrenaline and noradrenaline excretion. Thorax (1977) 1.66
Pulmonary haemosiderosis and pulmonary haemorrhage. Br J Dis Chest (1981) 1.56
Aspergillus fumigatus and lung disease. Postgrad Med J (1979) 1.52
High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis (1976) 1.51
Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clin Exp Immunol (1978) 1.50
Chronic bronchial suppuration and inflammatory bowel disease. Q J Med (1981) 1.50
Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. Br J Dis Chest (1981) 1.49
Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies. Clin Allergy (1971) 1.47
Can exposure to coalmine dust cause a severe impairment of lung function? Br J Ind Med (1986) 1.47
Respiratory health effects of opencast coalmining: a cross sectional study of current workers. Occup Environ Med (1997) 1.45
Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet (1982) 1.45
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
The British Thoracic Society. Thorax (1982) 1.42
Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis (1991) 1.41
Pulmonary disease in Behçet's syndrome. Q J Med (1986) 1.39
Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis). Thorax (1983) 1.39
Nedocromil sodium workshop. Respir Med (1989) 1.38
Computed tomography in adult obliterative bronchiolitis. Clin Radiol (1990) 1.38
Letter: Disability and coal workers' pneumoconiosis. Br Med J (1974) 1.38
Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax (1979) 1.33
Ultrastructural changes in bronchoalveolar lavage cells in sarcoidosis and comparison with the tissue granuloma. Am J Pathol (1983) 1.31
Risks of silicosis in coalworkers exposed to unusual concentrations of respirable quartz. Occup Environ Med (1998) 1.30
Progressive massive fibrosis and simple pneumoconiosis in ex-miners. Br J Ind Med (1985) 1.28
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. Thorax (1983) 1.28
Cytophilic antibodies in bronchopulmonary aspergilloma and cryptogenic pulmonary eosinophilia. Clin Exp Immunol (1976) 1.28
Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol (1985) 1.28
Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol (1985) 1.25
Distribution of plasma cells and other cells containing immunoglobulin in the respiratory tract in chronic bronchitis. Thorax (1977) 1.24
A case of pulmonary veno-occlusive disease respondong to treatment with azathioprine. Thorax (1977) 1.24
Diagnosis and management of alveolar proteinosis: the rôle of electron microscopy. Thorax (1975) 1.23
Factors influencing the prevalence of asthma among first degree relatives of extrinsic and intrinsic asthmatics. Thorax (1979) 1.22
Pulmonary veno-occlusion--an immune complex disease? Virchows Arch A Pathol Anat Histol (1974) 1.21
The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis (1987) 1.20
Smooth muscle antibody in bronchial asthma. Clin Exp Immunol (1970) 1.20
Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax (1981) 1.18
Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs. Proc R Soc Med (1974) 1.17
The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs. Q J Med (1971) 1.17
Reversed anaphylactic reaction of leucocytes in intrinsic asthma. Clin Allergy (1971) 1.14
Emphysema in coalworkers. Br Med J (1970) 1.14
Assay of circulating immunoglobulins in patients with fibrosing alveolitis. Clin Exp Immunol (1967) 1.14
Radiographic progression of asbestosis: preliminary report. Ann N Y Acad Sci (1979) 1.14
Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med (1989) 1.11
Cryptogenic pulmonary eosinophilia. Clin Allergy (1976) 1.11
Autoantibodies in iodide goitre and asthma. Clin Exp Immunol (1966) 1.10
Breath sounds in emphysema. Br J Dis Chest (1969) 1.10
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax (1984) 1.08
Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases. Am Rev Respir Dis (1987) 1.08
Identification of inorganic dust particles in bronchoalveolar lavage macrophages by energy dispersive x-ray microanalysis. Arch Environ Health (1986) 1.07
Questionnaire for the identification of back pain for epidemiological purposes. Occup Environ Med (1994) 1.06
Relations between upper limb soft tissue disorders and repetitive movements at work. Am J Ind Med (1995) 1.06
Asbestos-related disorders. Br J Dis Chest (1973) 1.06
Quantitative relations between exposure to respirable quartz and risk of silicosis. Occup Environ Med (2003) 1.06
Skin tests with tuberculin (PPD) Candida albicans and Trichophyton spp. in cryptogenic fibrosing alveolitis and asbestos related lung disease. Clin Allergy (1980) 1.04
Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1981) 1.03
Studies in chronic allergic bronchopulmonary aspergillosis. 4. Comparison with a group of asthmatics. Thorax (1977) 1.03
Histocompatibility antigens in coal miners with pneumoconiosis. Br J Ind Med (1983) 1.02
Epidemiologic study of back pain in miners and office workers. Spine (Phila Pa 1976) (1986) 1.01
Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis. Clin Sci (Lond) (1986) 1.01
The significance of antinuclear and DNA antibodies in cryptogenic fibrosing alveolitis. Thorax (1983) 0.99
Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study. Clin Exp Immunol (1976) 0.99
Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg (1999) 0.99
Lymphocyte sensitization to Aspergillus fumigatus antigens in pulmonary diseases in man. Clin Allergy (1976) 0.99
Multiorgan granulomas and mitochondrial antibodies. N Engl J Med (1983) 0.99
Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax (1984) 0.99
Immunology and asbestosis. Proc R Soc Med (1973) 0.99
Lung function studies in asbestos workers. Br J Dis Chest (1972) 0.98
Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Coll Relat Res (1984) 0.98
Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg (1999) 0.97
Update on lung disease in coalminers. Br J Ind Med (1987) 0.96
Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis (1986) 0.96
Maximal expiratory flow volume curves in workers exposed to asbestos. Respiration (1980) 0.96
Distribution of plasma cells and other cells containing immunoglobulin in the respiratory tract of normal man and class of immunoglobulin contained therein. Thorax (1976) 0.96
Risks of respiratory disease in the heavy clay industry. Occup Environ Med (1999) 0.95